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Healthcare-associated infections are common, costly, and
potentially deadly. However, effective prevention strategies
are underutilized, particularly for catheter-associated uri-
nary tract infection (CAUTI), one of the most common
healthcare-associated infections. Further, since 2008, the
Centers for Medicare and Medicaid Services no longer
reimburses hospitals for the additional costs of caring for
patients who develop CAUTI during hospitalization. Given
the resulting payment pressures on hospitals stemming
from this decision, it is important to factor in cost implica-
tions when attempting to encourage decision makers to
support infection prevention measures. To this end, we
present a simple tool (with easy-to-use online implementa-
tion) that hospitals can use to estimate hospital costs due
to CAUTI, both before and after an intervention, to reduce
inappropriate urinary catheterization. Using previously pub-
lished cost and risk estimates, we show that an intervention
yielding clinically feasible reductions in catheter use can
lead to an estimated 50% reduction in CAUTI-related costs.
Our tool is meant to complement the Society of Hospital
Medicine’s Choosing Wisely campaign, which highlights
avoiding placement or continued use of nonindicated
urinary catheters as a key area for improving decision
making and quality of care while decreasing costs.
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Healthcare-associated infections affect 5% to 10% of
all hospitalized patients each year in the United States,
account for nearly $45 billion in direct hospital costs,
and cause nearly 100,000 deaths annually.1,2 Because
catheter-associated urinary tract infection (CAUTI) is
one of the most common healthcare-associated infec-
tions in the United States and is reasonably prevent-
able, the Centers for Medicare and Medicaid Services
stopped reimbursing hospitals in 2008 for the addi-
tional costs of caring for patients who develop CAUTI
during hospitalization.3 Still, strategies for reducing
inappropriate urinary catheterization are infrequently
implemented in practice; this is despite a consensus
that such strategies are effective.4
To help motivate hospitals to reduce inappropriate
urinary catheter use, we present a tool for estimating
costs of CAUTI for individual hospitals. Although other
tools for estimating the excess costs of healthcare-
associated infections are available (eg, the APIC Cost of
Healthcare-Associated Infections Model available at
http://www.apic.org/Resources/Cost-calculators), they
do not provide estimates of potential cost savings. Our
approach adds to the literature by providing estimates
of a hospital’s current costs based on a few simple
inputs (eg, annual admissions and catheterization rate),
and also yields projected costs after a hypothetical
intervention to prevent infections. Results are derived
by combining appropriate cost and risk estimates from
the literature. Importantly, an online implementation of
our approach is available that can be easily used by
clinicians, hospital administrators, and national policy-
makers. Our implementation nicely complements efforts
like the Society of Hospital Medicine’s Choosing Wisely
campaign, which highlights avoiding inappropriate
urinary catheter use first on its list of Five Things Physi-
cians and Patients Should Question, and aims to
increase awareness about issues that could improve
patient outcomes and reduce healthcare costs.5 Although
accounting for the full spectrum of institution-specific
costs (eg, actual intervention costs, opportunity costs)
was beyond the scope of this work, the simple tool we
present helps meet the primary goal of generating an




We consider 4 possible events after urinary catheter
placement: bacteriuria, symptomatic urinary tract
infection (SUTI), bloodstream infection (BSI), and
catheter removal. Conservatively, assuming that bac-
teriuria must precede SUTI and BSI, there are 5 possi-
ble trajectories for any hospitalized patient (Figure 1):
(1) no infection, (2) only bacteriuria, (3) bacteriuria
and SUTI, (4) bacteriuria and BSI, or (5) bacteriuria,
SUTI, and BSI. The cost of CAUTI for a particular
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hospital is therefore the per-patient cost of each tra-
jectory multiplied by the number of patients experi-
encing each trajectory. Our approach for estimating
hospital costs is based on factorizing the number of
patients experiencing each trajectory into a product of
terms for which estimates are available from the litera-
ture (see the Supporting Information, Appendix, in the
online version of this article for all technical details).
Deriving Estimates of Current Costs
We start with 2 minor simplifying assumptions. First,
because the presence of asymptomatic bacteriuria is
typically unknown, we only consider costs to the hos-
pital due to SUTI and BSI6; in other words, we
assume hospitals do not incur costs for patients with
trajectories 1 or 2. This assumption should only bias
cost estimates conservatively. Second, we assume that
patients with both SUTI and BSI (trajectory 5) incur
costs equal to those for patients with only BSI (trajec-
tory 4). Further, because the joint risk of SUTI and
BSI is unknown, we conservatively assume SUTI must
precede BSI. Under these assumptions we can write:
(total CAUTI costs)5 (per-patient SUTI cost) 3 (num-
ber with SUTI but no BSI)1 (perpatient BSI cost) 3
(number with BSI).
We use per-patient hospital costs of SUTI and BSI
of $911 and $3824, respectively, which were deter-
mined using a microcosting approach6 and adjusted
for inflation using the general Consumer Price Index.7
Although an alternative strategy for estimating costs
would be to enter the hospital-specific, per-patient
costs of SUTI and BSI into the above equation, these
quantities are often difficult to measure or otherwise
unavailable. Thus, it remains to factorize the number
of hospitalized patients who develop SUTI and BSI
into component terms for which we have accessible
estimates. First note that the number with only SUTI
(or any BSI) equals the total number of patients hospi-
talized times the proportion of hospitalizations with
only SUTI (or any BSI). The former quantity depends
on the particular hospital and so is specified as an
input by the user. The latter quantity can be factorized
further under our aforementioned conservative assump-
tion that bacteriuria must precede SUTI and BSI.
Specifically, for SUTI:
(Proportion SUTI but no BSI)5 {(SUTI risk among
those catheterized with bacteriuria)2 (BSI risk among
those catheterized with bacteriuria)} 3 (bacteriuria risk
among those catheterized) 3 (proportion catheterized).
And for BSI:
(Proportion BSI)5 (BSI risk among those catheter-
ized with bacteriuria) 3 (bacteriuria risk among those
catheterized) 3 (proportion catheterized).
The risks of SUTI and BSI among those catheterized
with bacteriuria, along with the risk of bacteriuria
among those catheterized, have been estimated previ-
ously via a meta-analytic approach.6 The proportion
catheterized depends on the particular hospital, such
as the total number of patients hospitalized, and so is
also specified as a user input. Therefore, we have now
factorized the total hospital costs due to CAUTI as a
product of either user-specified terms or terms for
which we have estimates from the literature. All esti-
mates and corresponding standard errors derived from
the literature are listed together in Table 1 (see the
Supporting Information, Appendix Section 1, for fur-
ther details in the online version of this article).
Deriving Projected Costs After Intervention
The approach described above permits estimation of
current costs for managing patients with CAUTI for a
particular hospital. To estimate projected costs after
participation in an intervention to reduce infection risk,
we characterize interventions of interest and introduce
additional factorization. Specifically, following previous
work,8 we consider interventions that reduce (1) place-
ment (ie, the proportion catheterized) and (2) duration
(ie, the mean duration of catheterization). Incorporat-
ing reductions in placement is straightforward, because
our above expression for costs already contains a term
for the proportion catheterized. However, incorporat-
ing reductions in duration requires further factoriza-
tion. Under the assumptions of constant per-day risks
of bacteriuria and of catheter removal, we can write
the postintervention risk of bacteriuria among the
catheterized as a function of (1) the percent decrease in
mean duration of catheterization due to intervention,
and (2) the preintervention risk of bacteriuria among
the catheterized (see the Supporting Information,
FIG. 1. Possible patient trajectories. Abbreviations: BSI, bloodstream infec-
tion; SUTI, symptomatic urinary tract infection.
TABLE 1. Input Values Used in Estimating Hospital
Costs Due to Catheter-Associated Urinary Tract
Infection
Quantity Estimate (SE)
Overall risk of bacteriuria among those catheterized 26.0% (1.53%)
Per-day risk of bacteriuria among those catheterized 5.0%
days 6.68
Risk of SUTI among those catheterized with bacteriuria 24.0% (4.08%)
Risk of BSI among those catheterized with bacteriuria 3.6% (0.10%)
Per-patient SUTI cost $911 ($911)
Per-patient BSI cost $3824 ($3824)
NOTE: Abbreviations: BSI, bloodstream infection; SE, standard error; SUTI,
symptomatic urinary tract infection. Most values were derived from or origi-
nally published in Saint (2000).6 Costs were inflation adjusted using the gen-
eral Consumer Price Index.
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Appendix Section 2, for further details in the online ver-
sion of this article). This means we can fully characterize
postintervention costs as a function of user-specified
quantities, quantities specific to the intervention (which
are varied across plausible ranges), and quantities for
which we have estimates from the literature. Therefore,
we can estimate savings by subtracting postintervention
costs from current costs.
Because our estimators of current costs, projected
costs, and savings are all formulated as functions of
other estimators, we use the standard delta method
approach9 to derive appropriate variance estimates
(see the Supporting Information, Appendix Section 3,
for further details in the online version of this article).
Online Implementation
Customized results (based on annual admissions, uri-
nary catheter prevalence, and other inputs) can be
computed using online implementation of our pro-
posed method at http://cauti.umms.med.umich.edu/
PHP/CAUTI_input.php. Although the work presented
in this article incorporates risk and cost estimates
from the literature whenever possible, the online
implementation allows full user specification of input
values.
RESULTS
Figure 2 shows the projected savings in hospital costs
due to CAUTI across a range of interventions defined
by percent decreases in placement and duration, for a
hypothetical hospital with 3000 total patients, 15%
with urinary catheters preintervention, and with all
other default values listed in Table 1. The current
costs for this hospital (ie, the costs when the percent
reduction in placement and duration is zero) are esti-
mated to be $37,868 (95% confidence interval [CI]:
$9159-$156,564). After an intervention resulting in
40% reductions in both urinary catheter placement
and duration, this hospital would be expected to save
$22,653 (95% CI: $5479-$93,656). A less effective
intervention yielding a 10% reduction in both urinary
catheter placement and duration would result in more
modest savings of $6376 (95% CI: $1542-$26,360).
After an intervention resulting in 29% and 37%
reductions in placement and duration, respectively,
reflecting reductions seen in practice,10,11 our hypo-
thetical hospital is estimated to save $19,126 (95%
CI: $4626-$79,074). This reflects an estimated savings
of nearly 50%.
DISCUSSION
We have presented a tool for estimating customized
hospital costs of CAUTI, both before and after a
hypothetical intervention to reduce risk of infection.
Our approach relies on mostly conservative assump-
tions, incorporates published risk estimates (properly
accounting for their associated variability), and has
easy-to-use online implementation. We believe this
can play an important role in motivating hospitals to
reduce inappropriate urinary catheter use.
The methodology employed here does have a few
limitations. First and foremost, our results depend on
the reliability of the input values, which are either
provided by users or are based on estimates from the
literature (see Table 1 for a complete list of suggested
defaults). New information could potentially be incor-
porated if and when available. For example, substitu-
tion of more precise risk estimates could help reduce
confidence interval length. Second, our approach
essentially averages over hospital quality; we do not
directly take into account quality of care or variation
in underlying infection risk across hospitals in com-
puting estimated costs. Finally, we only compute
direct costs due to infection; other costs (eg, interven-
tion costs) would typically also need to be considered
for decision making.
Despite these limitations, we believe that our tool
can help infection control professionals demonstrate
the values of CAUTI prevention efforts to key admin-
istrators, particularly at a time where it has become
increasingly necessary to develop a business case to
initiate new interventions or justify the continued sup-
port for ongoing programs.12 Additionally, we believe
the proposed approach can be an important supple-
ment to initiatives like the Society of Hospital Medi-
cine’s Choosing Wisely campaign, which aims to help
reduce inappropriate urinary catheter use. Reducing
catheter utilization has the potential to reduce costs
associated with caring for CAUTI patients, but more
importantly would help reduce CAUTI incidence as
well as catheter-related, noninfectious complica-
tions.13,14 We hope that our tool will greatly assist
hospitals in promoting their CAUTI prevention efforts
FIG. 2. Projected cost savings for a hypothetical hospital projections were
generated for a hypothetical hospital with 3000 total patients and 15% hav-
ing urinary catheters (ie, 450 patients catheterized prior to intervention) and
with default values given in Table 1. Abbreviations: CI, confidence interval.
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and improve the overall safety of hospitalized
patients.
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